The U.S. government is returning 8 million doses of Paxlovid to Pfizer as the biopharmaceutical company announces that it will sell the antiviral drug for $1,400 for a five-day course. This is nearly triple what the U.S. government paid for it. This as the efficacy of Paxlovid has never been definitively proven.
Watch: Here